
Annual report 2023
added 12-27-2025
Profound Medical Corp. Market Cap 2011-2026 | PROF
As of March 17, 2026 Profound Medical Corp. has a market cap of $ 180 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 230 M | 228 M | 121 M | 88.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 230 M | 88.1 M | 167 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
3.03 M | $ 2.2 | 4.27 % | $ 3.43 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 10.72 | 2.88 % | $ 1.45 B | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Butterfly Network
BFLY
|
766 M | $ 4.17 | 6.52 % | $ 883 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.37 | -0.12 % | $ 601 M | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 36.49 | -2.47 % | $ 1.13 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 12.76 | 1.23 % | $ 1.91 B | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.69 | 6.49 % | $ 37.6 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 4.12 | 3.91 % | $ 154 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 71.64 | 2.65 % | $ 106 B | ||
|
Establishment Labs Holdings
ESTA
|
2.31 B | $ 65.1 | 2.55 % | $ 1.93 B | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
466 M | $ 11.29 | 2.32 % | $ 305 M | ||
|
InMode Ltd.
INMD
|
928 M | $ 13.58 | 1.11 % | $ 878 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.31 | -1.5 % | $ 21.1 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 18.44 | 0.11 % | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.2 | 0.46 % | $ 1.34 M | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 62.23 | 1.29 % | $ 3.39 B | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
MiMedx Group
MDXG
|
779 M | $ 4.47 | 1.25 % | $ 661 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
196 B | $ 111.62 | 1.52 % | $ 194 B | ||
|
Delcath Systems
DCTH
|
326 M | $ 9.76 | -0.48 % | $ 350 M | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 268.07 | 2.61 % | $ 7.56 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.59 | -0.19 % | $ 152 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.19 | 2.0 % | $ 708 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 32.83 | -0.05 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
13.9 B | $ 176.11 | 3.93 % | $ 13.2 B | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 33.64 | 2.67 % | $ 5.01 K | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
142 M | $ 3.82 | 4.08 % | $ 157 M | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.1 | -0.06 % | $ 401 M |